GSK3B and Parkinson disease: In this study, based on the previous research, we suspected that neuroprotective effect of CFR against PD might be correlated with α-syn and GSK-3β/β-catenin signaling, in vivo and in vitro models of PD induced with α-syn were established, and neuroprotective effect and possible mechanism of CFR were also explored.